Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Share-based Compensation (2010 - 2026)

Geron's (GERN) quarterly Share-based Compensation came in at $4.9 million in Q2 2026, down 26.83% year-over-year from $6.8 million in Q2 2025, and up 0.73% quarter-over-quarter from $4.9 million in Q1 2026.

Analysis

Geron (GERN) Share-based Compensation (2010 - 2026) Analysis & Trends

Geron has disclosed Share-based Compensation across 17 years of filings, most recently posting $4.9 million for Q2 2026.

  • In Q2 2026, Share-based Compensation fell 26.83% year-over-year to $4.9 million; the TTM figure through Jun 2026 stood at $22.3 million (down 19.86% YoY), while the FY2025 annual figure was $26.7 million, down 64.91% from the prior year.
  • Share-based Compensation came in at $4.9 million for Q2 2026 at Geron, up from $4.9 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $16.4 million in Q2 2024 to a low of $573000.0 in Q2 2023.
  • Average Share-based Compensation over 5 years is $5.5 million, with a median of $5.4 million recorded in 2025.
  • Year-over-year, Share-based Compensation soared 9852.94% in 2022 and plunged 58.69% in 2025.
  • Over 5 years, Share-based Compensation stood at $2.2 million in 2022, then surged by 101.83% to $4.4 million in 2023, then jumped by 53.83% to $6.8 million in 2024, then declined by 15.04% to $5.8 million in 2025, then fell by 14.24% to $4.9 million in 2026.
  • Per Business Quant data, the three most recent Share-based Compensation figures were $4.9 million in Q2 2026, $4.9 million in Q1 2026, and $5.8 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 247.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 231.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 108.10 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 243.00 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 120.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 86.63 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 77.40 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 83.34 Mn
10 Geron 914.60 Mn 613.75 Mn - 4.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.95 Mn
Mar 31, 2026 4.91 Mn
Dec 31, 2025 5.77 Mn
Sep 30, 2025 6.70 Mn
Jun 30, 2025 6.76 Mn
Mar 31, 2025 7.42 Mn
Dec 31, 2024 6.79 Mn
Sep 30, 2024 6.89 Mn
Jun 30, 2024 16.37 Mn
Mar 31, 2024 4.88 Mn
Dec 31, 2023 4.42 Mn
Sep 30, 2023 7.20 Mn
Jun 30, 2023 573,000.00
Mar 31, 2023 7.88 Mn
Dec 31, 2022 2.19 Mn
Sep 30, 2022 2.06 Mn
Jun 30, 2022 761,000.00
Mar 31, 2022 1.69 Mn
Dec 31, 2021 2.31 Mn
Sep 30, 2021 2.01 Mn